Ticker > Company >

Makers Laboratories share price

Makers Laboratories Ltd.

BSE: 506919 SECTOR: Pharmaceuticals & Drugs  11.57 K   8   0

141.35
-5.35 (-3.65%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 146.6

Today's Low

₹ 140.05

52 Week High

₹ 230

52 Week Low

₹ 122

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

83.4 Cr.

Enterprise Value

83.66 Cr.

No. of Shares

0.59 Cr.

P/E

14.91

P/B

1.49

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  94.58

CASH

0.04 Cr.

DEBT

0.3 Cr.

Promoter Holding

61.27 %

EPS (TTM)

₹  9.48

Sales Growth

-12.52%

ROE

8.63 %

ROCE

9.67%

Profit Growth

166.76 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-12.52%
3 Year-6.4%
5 Year-3.53%

Profit Growth

1 Year166.76%
3 Year200.05%
5 Year108.59%

ROE%

1 Year8.63%
3 Year-5.25%
5 Year-3.77%

ROCE %

1 Year9.67%
3 Year-2.12%
5 Year-0.82%

Debt/Equity

0.0053

Price to Cash Flow

-52.56

Interest Cover Ratio

6.2315

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 61.27 0.00
Mar 2025 61.27 0.00
Dec 2024 61.27 0.00
Sep 2024 61.27 0.00
Jun 2024 61.27 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 13.2852 Cr.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.0894366445111225.
  • The company has an efficient Cash Conversion Cycle of 9.521 days.
  • The company has a high promoter holding of 61.27%.

 Limitations

  • The company has shown a poor revenue growth of -6.40338602094643% for the Past 3 years.
  • Company has a poor ROE of -5.2513% over the past 3 years.
  • Company has a poor ROCE of -2.117% over the past 3 years
  • Company has negative cash flow from operations of -1.5868.
  • The company has a low EBITDA margin of -1.84742604020199% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 12.29 11.5 9.45 9.7 13.73
Total Expenditure 12.56 11.67 10.01 10.91 13.26
Operating Profit -0.27 -0.17 -0.56 -1.21 0.46
Other Income 0.14 10.19 0.57 0.03 0.04
Interest 0.39 0.33 0.13 0.09 0.1
Depreciation 0.72 0.71 0.73 0.69 0.7
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.24 8.98 -0.85 -1.97 -0.3
Tax -0.02 0.95 -0.08 -0.57 -0.03
Profit After Tax -1.22 8.03 -0.77 -1.4 -0.27
Adjusted EPS (Rs) -2.07 13.62 -1.31 -2.37 -0.46

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 44.41 52.38 42.55 49.09 42.94
Total Expenditure 41.1 49.32 46.68 52.85 45.15
Operating Profit 3.31 3.05 -4.13 -3.76 -2.21
Other Income 0.41 0.85 1.14 1.15 10.92
Interest 1.6 1.68 1.38 1.63 0.94
Depreciation 4.2 1.91 2.4 2.71 2.85
Exceptional Items 0 0 0 0 0
Profit Before Tax -2.07 0.31 -6.78 -6.96 4.93
Tax -0.46 0.14 -0.41 -0.01 0.29
Net Profit -1.62 0.17 -6.36 -6.95 4.64
Adjusted EPS (Rs.) -3.15 0.35 -10.78 -11.78 7.87

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.92 4.92 5.9 5.9 5.9
Total Reserves 44.7 45.38 52.38 45.55 50.18
Borrowings 5.53 2.69 2.39 6 0
Other N/C liabilities 2.9 2.79 3.2 2.96 1.85
Current liabilities 21.07 29.71 20.91 25.73 13.47
Total Liabilities 79.12 85.48 84.79 86.15 71.4
Assets
Net Block 30.59 29.94 40.45 39.88 29.38
Capital WIP 0.12 8.94 0.01 0 0.04
Intangible WIP 0 0 0.03 0 0
Investments 23.66 22.55 22.52 22.56 22.59
Loans & Advances 1.5 2.69 2.58 2.83 3.28
Other N/C Assets 0.04 0.01 0.04 0.03 0.05
Current Assets 23.2 21.35 19.16 20.85 16.06
Total Assets 79.12 85.48 84.79 86.15 71.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -2.07 0.31 -6.78 -6.96 4.93
Adjustment 5.47 3.29 3.33 3.64 -6.73
Changes in Assets & Liabilities -1.35 3.75 2.42 0.57 0.65
Tax Paid -1.38 -0.55 -0.4 -0.32 -0.44
Operating Cash Flow 0.67 6.8 -1.42 -3.06 -1.59
Investing Cash Flow -2.65 -8.78 -3.55 -2.04 16.14
Financing Cash Flow 1.37 1.77 4.94 5.12 -14.56
Net Cash Flow -0.61 -0.21 -0.04 0.02 -0.01

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 61.27 61.27 61.27 61.27 61.27
bhawna godha 0.72 0.72 0.72 0.72 0.72
chandurkar investments pr... 1.43 1.43 1.43 1.43 1.43
kaygee investments privat... 17.38 17.38 17.38 17.38 17.38
kaygee laboratories priva... 14.35 14.35 14.35 14.35 14.35
mexin medicaments private... 3.12 3.12 3.12 3.12 3.12
nirmal gigalal jain 1.62 1.62 1.62 1.62 1.62
paschim chemicals pvt ltd... 16.38 16.38 16.38 16.38 16.38
prashant godha 2.08 2.08 2.08 2.08 2.08
premchand godha 2.15 2.15 2.15 2.15 2.15
sameer m chandurkar 0.37 0.37 0.37 0.37 0.37
usha m chandurkar 0.69 0.69 0.69 0.69 0.69
usha premchand godha 0.97 0.97 0.97 0.97 0.97
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 38.73 38.73 38.73 38.73 38.73
investor education and pr... 2.57 2.57 2.74 2.74 2.74
kiran rashmin rughani - 1.15 1.36 1.37 1.37
llp 0.03 0.03 0.06 0.01 0.01
tanvi jignesh mehta 1.76 2.16 2.12 2.16 2.18
achyutkumar ratilal modi 1.07 1.07 1.03 - -
vishal jain 0.13 0.13 0.13 - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
Credit CARE RATINGS
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.Report us

Makers Laboratories Stock Price Analysis and Quick Research Report. Is Makers Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Makers Laboratories. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Makers Laboratories has a PE ratio of 14.9144280076814 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Makers Laboratories has ROA of 5.8919% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Makers Laboratories has a Current ratio of 1.1919.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Makers Laboratories has a ROE of 8.6328%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Makers Laboratories has a Debt to Equity ratio of 0.0053 which means that the company has low proportion of debt in its capital.

  • Sales growth: Makers Laboratories has reported revenue growth of -12.516% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Makers Laboratories for the current financial year is -5.13778216586021%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Makers Laboratories is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Makers Laboratories is Rs 9.4774. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Makers Laboratories in Ticker for free. Also, one can get the intrinsic value of Makers Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Makers Laboratories FAQs

Q1. What is Makers Laboratories share price today?
Ans: The current share price of Makers Laboratories is Rs 141.35.

Q2. What is the market capitalisation of Makers Laboratories?
Ans: Makers Laboratories has a market capitalisation of Rs 83.40181476 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Makers Laboratories?
Ans: The PE ratio of Makers Laboratories is 14.9144280076814 and the P/B ratio of Makers Laboratories is 1.4945383531213, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Makers Laboratories share?
Ans: The 52-week high share price of Makers Laboratories is Rs 230, and the 52-week low share price of Makers Laboratories is Rs 122.

Q5. Does Makers Laboratories pay dividends?
Ans: Currently, Makers Laboratories does not pay dividends. Dividend yield of Makers Laboratories is around 0%.

Q6. What are the face value and book value of Makers Laboratories shares?
Ans: The face value of Makers Laboratories shares is Rs 10, while the book value per share of Makers Laboratories is around Rs 94.5777. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Makers Laboratories?
Ans: Makers Laboratories has a total debt of Rs 0.2964 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Makers Laboratories?
Ans: The ROE of Makers Laboratories is 8.6328% and ROCE of Makers Laboratories is 9.6716%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Makers Laboratories a good buy for the long term?
Ans: The Makers Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Makers Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Makers Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Makers Laboratories’s financials?
Ans: You can review Makers Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Makers Laboratories
X